Editorial
doi: 10.1016/j.jacc.2004.03.023.
Soluble CD40 ligand and platelets: self-perpetuating pathogenic loop in thrombosis and inflammation?
- PMID: 15193701
- DOI: 10.1016/j.jacc.2004.03.023
Item in Clipboard
Editorial
Soluble CD40 ligand and platelets: self-perpetuating pathogenic loop in thrombosis and inflammation?
J Am Coll Cardiol.
.
Free article
No abstract available
Comment on
-
Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization.J Am Coll Cardiol. 2004 Jun 16;43(12):2319-25. doi: 10.1016/j.jacc.2003.12.055. J Am Coll Cardiol. 2004. PMID: 15193700
Similar articles
-
Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization.J Am Coll Cardiol. 2004 Jun 16;43(12):2319-25. doi: 10.1016/j.jacc.2003.12.055. J Am Coll Cardiol. 2004. PMID: 15193700
-
P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonist.Platelets. 2003 Nov-Dec;14(7-8):473-80. doi: 10.1080/09537100310001638562. Platelets. 2003. PMID: 14713516
-
ADAM 15 is an adhesion receptor for platelet GPIIb-IIIa and induces platelet activation.Thromb Haemost. 2005 Sep;94(3):555-61. doi: 10.1160/TH04-12-0784. Thromb Haemost. 2005. PMID: 16268472
-
[Blockers of platelet glycoprotein IIb/IIIa-receptors in the treatment of patients with acute coronary syndrome and during transcutaneous coronary interventions].Ter Arkh. 2009;81(1):84-7. Ter Arkh. 2009. PMID: 19253720 Review. Russian. No abstract available.
-
Pharmacological approaches to studying platelet function: an overview.Methods Mol Biol. 2004;273:73-86. doi: 10.1385/1-59259-783-1:073. Methods Mol Biol. 2004. PMID: 15308794 Review. No abstract available.
Cited by
-
Systemic biomarkers of inflammation and haemostasis in patients with chronic necrotizing pulmonary aspergillosis.BMC Infect Dis. 2012 Jun 25;12:144. doi: 10.1186/1471-2334-12-144. BMC Infect Dis. 2012. PMID: 22731696 Free PMC article.
-
An αIIbβ3 ligand-mimetic murine monoclonal antibody that produces platelet activation by engaging the FcγIIa receptor.Blood Adv. 2025 Jul 22;9(14):3518-3529. doi: 10.1182/bloodadvances.2024015368. Blood Adv. 2025. PMID: 40101235 Free PMC article.
-
Does anti-TNF therapy cause any change in platelet activation in ankylosing spondylitis patients? A comparative study.J Thromb Thrombolysis. 2012 Feb;33(2):154-9. doi: 10.1007/s11239-011-0663-9. J Thromb Thrombolysis. 2012. PMID: 22173846
-
Nuclear factor of activated T cells (NFAT) mediates CD154 expression in megakaryocytes.Blood. 2008 Apr 1;111(7):3553-61. doi: 10.1182/blood-2007-05-088161. Epub 2008 Jan 7. Blood. 2008. PMID: 18180380 Free PMC article.
-
Personalized Dual Antiplatelet Therapy in Acute Coronary Syndromes: Striking a Balance Between Bleeding and Thrombosis.Curr Cardiol Rep. 2023 Jul;25(7):693-710. doi: 10.1007/s11886-023-01892-9. Epub 2023 Jun 1. Curr Cardiol Rep. 2023. PMID: 37261665 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
